SCLX Scilex Holding Company

Price (delayed)

$5.1

Market cap

$43.31M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$49.7

Enterprise value

$148.73M

?
Relative Growth: Rel. Growth: 1
Relative Strength: Rel. Strength: 5
Relative Valuation: Rel. Valuation: 27
Relative Profitability: Rel. Profitability: 6

Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and, following the formation ...

Highlights
SCLX's debt has surged by 115% year-on-year
SCLX's gross profit is down by 44% year-on-year and by 13% since the previous quarter

Key stats

What are the main financial stats of SCLX

SCLX stock price

How has the Scilex Holding stock price performed over time
Intraday
-4.67%
1 week
-1.35%
1 month
-10.99%
1 year
-82.29%
YTD
-58.2%
QTD
-34.62%

Financial performance

How have Scilex Holding's revenue and profit performed over time
Revenue
$31.61M
Gross profit
$17.54M
Operating income
-$359.19M
Net income
-$447.12M
Gross margin
55.5%
Net margin
-1,414.6%
SCLX's gross profit is down by 44% year-on-year and by 13% since the previous quarter
Scilex Holding's revenue has decreased by 29% YoY and by 7% from the previous quarter
SCLX's net margin is down by 27% since the previous quarter
The gross margin has declined by 21% year-on-year and by 7% since the previous quarter

Price vs fundamentals

How does SCLX's price correlate with its fundamentals

Growth

What is Scilex Holding's growth rate over time

Valuation

What is Scilex Holding stock price valuation
P/E
N/A
P/B
N/A
P/S
1.11
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.71
The EPS has contracted by 23% from the previous quarter
SCLX's equity is down by 24% YoY and by 21% from the previous quarter
The price to sales (P/S) is 93% lower than the 5-year quarterly average of 17.5 and 65% lower than the last 4 quarters average of 3.3
Scilex Holding's revenue has decreased by 29% YoY and by 7% from the previous quarter

Efficiency

How efficient is Scilex Holding business performance
The ROS has contracted by 27% from the previous quarter
The ROA has contracted by 9% YoY but it has grown by 8% from the previous quarter

Dividends

What is SCLX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SCLX.

Financial health

How did Scilex Holding financials performed over time
The total assets is 55% smaller than the total liabilities
The total liabilities has soared by 70% year-on-year and by 3% since the previous quarter
Scilex Holding's current ratio has decreased by 36% YoY and by 13% QoQ
SCLX's debt is 134% greater than its equity
SCLX's debt has surged by 115% year-on-year
Scilex Holding's debt to equity has plunged by 70% YoY but it has increased by 19% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.